Choose your location
Holistic approach to China equity investing
- Seek attractive investment opportunities across Chinese companies listed both onshore and offshore
- Being benchmark-unconstrained, the fund manager takes a truly active approach
Investing in change
- Identify change in business fundamentals or investor behaviour
- We believe mispricing could arise in areas where future fundamentals will be different from the past
Looking beyond the obvious
- The team seeks to go beyond the top 100 mega-cap names1 and focus on the less efficient part of the market
- That translates roughly to a market cap range of US$20-30 billion or below today
China Evolution Equity Fund
10 August 2020
Up to 1.70% p.a.
MSCI China All Shares Index Net
Ready to discuss your investment plans?
Standard Chartered Bank Singapore is our exclusive distributor for the T. Rowe Price Funds SICAV - China Evolution Equity Fund.
Please reach out to Standard Chartered for further enquiries.
Why T. Rowe Price?
Heritage of success
Established in 1937, we are a diversified business, having been investing in emerging markets since 1980. Our demonstrated track record across markets lends confidence to investors.
Scale and size
We manage over US$18.54 billion of assets2 in China related equities, covering both securities listed in mainland China and on offshore exchanges.
Research is in our DNA
The breadth and depth of our 404 global research professionals3 provide a critical information edge to find the best investment ideas.
2 All figures as at 31 March 2023. Firmwide AUM includes assets managed by T. Rowe Price Associates, Inc. and its investment advisory affiliates.
3 Source: T. Rowe Price. All figures as at 31 March 2023. 11 sector portfolio managers, 202 investment analysts, 83 associate research analysts, 43 specialty analysts, 61 quantitative analysts, and 4 economists.
Our collective views and insights
Certain materials are more than 12 months old and may be outdated. They are provided for historical purposes only.
MSCI and its affiliates and third party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
Unless otherwise stated, all data is as of 31 March 2023 and sourced from T. Rowe Price. Certain numbers in this website may not add due to rounding and/or the exclusion of cash.
Investment involves risk. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can fall as well as rise. You may get back less than the amounted invested. The performance returns are denominated in the share class dealing currency which can be a foreign currency and if so, US/SG dollar-based investors are exposed to fluctuations in the US/SG dollar/foreign currency exchange rate. Before deciding to invest in the fund, you should read the offering document/prospectus (including its investment objectives, policies and any risk warnings) and the product highlights sheet which are available and may be obtained from any appointed distributors.
T. Rowe Price Singapore Private Ltd. is the appointed Singapore representative and agent for service of process in Singapore. SICAV refers to the T. Rowe Price Funds SICAV, a Luxembourg investment company with variable capital which is registered with Commission de Surveillance du Secteur Financier and which qualifies as an undertaking for collective investment in transferable securities (“UCITS”).